AZN.L : Summary for ASTRAZENECA PLC ORD SHS $0.25 - Yahoo Finance

U.S. Markets close in 1 hr 48 mins

AstraZeneca PLC (AZN.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
4,116.00+109.00 (+2.72%)
At close: 12:14 PM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close4,007.00
Open4,028.50
Bid4,025.00 x 6100
Ask4,500.00 x 13000
Day's Range4,011.00 - 4,201.50
52 Week Range3,680.00 - 5,505.00
Volume3,867,870
Avg. Volume2,742,296
Market Cap52.07B
BetaN/A
PE Ratio (TTM)21.12
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Associated Press52 minutes ago

    AstraZeneca cuts about 700 jobs, including 120 in Delaware

    DOVER, Del. (AP) — British-based pharmaceutical company AstraZeneca says it is eliminating about 700 jobs in its U.S. commercial business, including about 120 at its North American headquarters in Wilmington.

  • 24/7 Wall St.22 hours ago

    Hanesbrands, AstraZeneca Plop into Wednesday’s 52-Week Low Club

    December 7, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by more than 3 to 1 and ...

  • Can AstraZeneca Plc (AZN) Lung Cancer Pill Take Over Chemo Treatment?
    Insider Monkeyyesterday

    Can AstraZeneca Plc (AZN) Lung Cancer Pill Take Over Chemo Treatment?

    Tagrisso, a lung cancer med from AstraZeneca plc (ADR) (NYSE:AZN) is already in early approval based on mid-stage studies, which demonstrates the possibility of it replacing the standard chemotherapy for lung cancer. In a major clinical trial, the blockbuster described as an important pillar in the company’s big sales ambitions exhibited advances in progression-free survival. […]